1.
Australas J Dermatol
; 62(3): e411-e413, 2021 Aug.
Article
in English
| MEDLINE
| ID: mdl-34170516
ABSTRACT
Purpureocillium lilacinum, previously classified as Paecilomyces lilacinus, is a ubiquitous hyaline hyphomycete considered to be an emerging opportunistic human pathogen that is resistant to traditional antifungal agents. This case report describes what is to our knowledge the only published case of P. lilacinum recrudescence in an immunocompetent host despite initial best-practice treatment with 10 weeks of voriconazole and surgical excision.